Retraction: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial

Bibliographic Details
Main Author: Frontiers Editorial Office
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Medicine
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.964099/full
_version_ 1818164123154776064
author Frontiers Editorial Office
author_facet Frontiers Editorial Office
author_sort Frontiers Editorial Office
collection DOAJ
first_indexed 2024-12-11T17:00:27Z
format Article
id doaj.art-30b70870749e4b3e9c06070b6b7f6a00
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-12-11T17:00:27Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-30b70870749e4b3e9c06070b6b7f6a002022-12-22T00:57:49ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-06-01910.3389/fmed.2022.964099964099Retraction: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled TrialFrontiers Editorial Officehttps://www.frontiersin.org/articles/10.3389/fmed.2022.964099/full
spellingShingle Frontiers Editorial Office
Retraction: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
Frontiers in Medicine
title Retraction: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
title_full Retraction: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
title_fullStr Retraction: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
title_full_unstemmed Retraction: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
title_short Retraction: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
title_sort retraction proxalutamide reduces the rate of hospitalization for covid 19 male outpatients a randomized double blinded placebo controlled trial
url https://www.frontiersin.org/articles/10.3389/fmed.2022.964099/full
work_keys_str_mv AT frontierseditorialoffice retractionproxalutamidereducestherateofhospitalizationforcovid19maleoutpatientsarandomizeddoubleblindedplacebocontrolledtrial